Follow Up from KEEPS trial confirms hormone therapy has no significant cardiac benefit Medha Baranwal Baranwal22 July 2018 7:25 PM ISTThe cessation of menopausal hormone therapy (MHT), used for the treatment of menopausal symptoms, has no impact on the progression of carotid artery...
Linagliptin safe for heart of patients with type 2 diabetes: CARMELINA Trial Medha Baranwal Baranwal25 July 2018 7:28 PM ISTLinagliptin has met the primary endpoint, demonstrating cardiovascular (CV) safety similar to placebo, shows findings from the CARMELINA...
Limiting level of anaesthesia does not reduce postoperative delirium: JAMA Medha Baranwal Baranwal16 Aug 2018 7:20 PM ISTThe risk of postoperative delirium in older patients undergoing hip fracture repair is not reduced significantly with lighter sedation levels,...
First new upfront treatment Unresectable Liver Cancer Dr. Kamal Kant Kohli Kohli16 Aug 2018 7:05 PM ISTLenvatinib capsules have been approved (Lenvima, Eisai Inc.) as first-line treatment of patients with unresectable Liver Cancer or hepatocellular...
ARF occurs less frequently in CKD patients after PCI compared to CABG Medha Baranwal Baranwal20 Aug 2018 7:15 PM ISTPatients with chronic kidney disease (CKD) undergoing revascularization in the EXCEL trial had an increased rate of acute renal failure (ARF) and...
Oral semaglutide effective in diabetes with renal impairment: PIONEER 5 trial Medha Baranwal Baranwal24 Aug 2018 7:10 PM ISTThe pharmaceutical company Novo Nordisk has revealed that based on the results from Phase 3a PIONEER 5 trial, oral semaglutide has hit the mark in the...
Short course of steroids prevents hearing loss in kids due to otitis media Medha Baranwal Baranwal27 Aug 2018 8:20 PM ISTA short course of oral steroid (prednisolone) might help in the attainment of acceptable hearing in children experiencing persistent hearing loss due...
Daily Aspirin Fails in Primary Prevention of heart attack : ARRIVE Trial Vinay Singh singh27 Aug 2018 8:28 PM ISTA daily dose of 100 mg of Aspirin was not found effective in reducing the long-term risk for cardiovascular (CV) or cerebrovascular events, according...
Aspirin not good for primary CV prevention in diabetes patients: ASCEND trial Medha Baranwal Baranwal29 Aug 2018 8:20 PM ISTThe use of aspirin in diabetes patients reduced the risk of occlusive vascular events by 12% but its benefits were canceled by the increased risk of...
Corticosteroids therapy for sepsis: New Clinical guideline Vinay Singh singh30 Aug 2018 8:35 PM ISTThe guideline which appeared in the journal BMJ suggests that the intravenous corticosteroid treatment for sepsis is reasonable either to use or...
Long-term antiplatelet monotherapy not superior to DAPT: GLOBAL LEADERS Trial Medha Baranwal Baranwal1 Sept 2018 7:20 PM ISTLong-term antiplatelet monotherapy -- ticagrelor in combination with aspirin for 1 month followed by ticagrelor alone for 23 months -- is safe after...
Rivaroxaban has no benefit in cardiac illnesses not associated with AF: NEJM Medha Baranwal Baranwal1 Sept 2018 7:20 PM ISTRivaroxaban, an oral anticoagulant drug does not reduce the risk of death, stroke or myocardial infarction than placebo among patients with worsening...
